Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells

Author： Zhou Ting  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.33, Iss.5, 2012-10, pp. : 1299-1306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

By Sun Yanlin  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

By Huang Fang   Wu Xiao-Nan   Chen Jie   Wang Wen-Xiang   Lu ZuFu  

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-06 ,pp. : 1611-1616

Spandidos Publications

Access to resources Recommend Favorite

Targeting Intracellular Calcium Signaling ([Ca2+]i) to Overcome Acquired Multidrug Resistance of Cancer Cells: A Mini-Overview

By Büsselberg Dietrich   Florea Ana-Maria  

Cancers, Vol. 9, Iss. 5, 2017-05 ,pp. : 48-48

MDPI

Access to resources Recommend Favorite

Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death

By            

International Journal of Oncology, Vol. 42, Iss. 2, 2013-01 ,pp. : 721-732

Spandidos Publications

Access to resources Recommend Favorite

Homocamptothecin-Daunorubicin Association Overcomes Multidrug-Resistance in Breast Cancer MCF7 Cells

By Chauvier D.   Morjani H.   Manfait M.  

Breast Cancer Research and Treatment, Vol. 73, Iss. 2, 2002-05 ,pp. : 113-125

Springer Publishing Company

Access to resources Recommend Favorite